Skip to main content

GSK Prescribes A US$3.5bn Bond In Three Parts

British pharma GlaxoSmithKline joined the recent groundswell of high-grade corporate bond issuers Monday to sell new debt.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.